| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 05/13/1997 | US5629329 Methods for treating disorders associated with the central nervous system using opticallly pure (+) cisapride |
| 05/13/1997 | US5629328 Antiemetic agent |
| 05/13/1997 | US5629327 Methods and compositions for inhibition of angiogenesis |
| 05/13/1997 | US5629326 Analgesics and antipsychotics, indazole, benzisoxazole, and benzisothiazole derivatives |
| 05/13/1997 | US5629325 3-pyridyloxymethyl heterocyclic ether compounds useful in controlling chemical synaptic transmission |
| 05/13/1997 | US5629324 Anticoagulants |
| 05/13/1997 | US5629323 Amide derivatives as 5-HT1A ligands |
| 05/13/1997 | US5629322 Treatment of neurodegenerative disorders, disorders of gastrointestinal motility and inflammation |
| 05/13/1997 | US5629320 3-quinolyl-substituted dihydropyridines, and their use in medicaments |
| 05/13/1997 | US5629319 Quindoline alkaloids |
| 05/13/1997 | US5629318 Method of treatment of chronic prostatitis with 17β-N-monosubstituted-carbamoyl-4-aza-5α-androst-1-en-3-ones |
| 05/13/1997 | US5629317 Serotonin antagonist |
| 05/13/1997 | US5629316 Stabilized solid pharmaceutical preparation and method of producing the same |
| 05/13/1997 | US5629315 Treatment of psoriasis, asthma,osteoporosis, alcoholic hepatitis, and premature labor |
| 05/13/1997 | US5629312 Reducing neuron damage caused by gp-120 protein in aids patients |
| 05/13/1997 | US5629311 Substituted cyclohexanol esters their use for treating diseases and pharmaceutical preparations |
| 05/13/1997 | US5629308 Imidazo [1,2-A] (pyrrolo, thieno or furano) [2,3-D] azepine derivatives |
| 05/13/1997 | US5629307 Use of ibogaine in reducing excitotoxic brain damage |
| 05/13/1997 | US5629306 B-lactamase inhibitors |
| 05/13/1997 | US5629305 Synergistic combination of a substance with gastric acid secretion inhibiting effect and an acid degradable antibiotic |
| 05/13/1997 | US5629304 Therapeutic agent for thrombocytopenia and indolocarbazole derivatives |
| 05/13/1997 | US5629303 Controlled release systems and low dose androgens |
| 05/13/1997 | US5629302 Biotenside esters and phosphatides with vitamin-D and vitamin-E compounds; processes for their preparation; spontaneously dispersible agents containing these compounds, and their use for the treatment of tumors |
| 05/13/1997 | US5629301 Comprising salicylic acid, a surfactant and a carrier; cleaning compounds |
| 05/13/1997 | US5629300 Drug containing (-)-metriphonate |
| 05/13/1997 | US5629298 Increasing contractile performance, adenosine transport inhibitors used as potentiators |
| 05/13/1997 | US5629297 Administering ranitidine bismuth citrate and helicobacter inhibiting antibiotics |
| 05/13/1997 | US5629296 Bactericides, antibiotics |
| 05/13/1997 | US5629295 Steroidal glycosides for treating hypercholesterolemia |
| 05/13/1997 | US5629289 Cyclic peptide antifungal agents |
| 05/13/1997 | US5629282 Antibacterial compositions |
| 05/13/1997 | US5629276 Composition of alkyl pyrrolidone for solubilizing antibacterials |
| 05/13/1997 | US5629198 Porphyrin derivative |
| 05/13/1997 | US5629184 To cell cytoplasm, antisense therapy |
| 05/13/1997 | US5629166 Cancer diagnosis |
| 05/13/1997 | US5629026 Gastric disorders |
| 05/13/1997 | US5629022 Galenic medicine in shaped form, able to be sucked or administered sublingually: porous, crosslinked, edible substrate; hydrophilic hydrocolloid polymer gel network in substrate; active product microcrystal dispersion |
| 05/13/1997 | US5629021 Drug delivery |
| 05/13/1997 | US5629020 Delivery of sensitive agents such as bioactive peptides |
| 05/13/1997 | US5629015 Composition for combating ageing acting simultaneously on the surface layers and deep layers of the skin and use thereof |
| 05/13/1997 | US5629011 Absorption promoters for derivatives of opioid analgesics |
| 05/13/1997 | US5629007 Using benzoquinolin-3-one derivatives |
| 05/13/1997 | US5629006 Skin disinfecting formulations |
| 05/13/1997 | US5629004 Emulsion containing stabilized ascorbic acid, cosmetic treatment process using it and uses thereof |
| 05/13/1997 | US5628999 Hypoglycemic agent from cryptolepis |
| 05/13/1997 | US5628988 Sunscreen agents |
| 05/13/1997 | US5628987 Pigmentation enhancer and method |
| 05/13/1997 | US5628984 Composition to promote lung mucus secretions |
| 05/13/1997 | US5628930 Stabilization of fluorocarbon emulsions |
| 05/13/1997 | CA2033183C Water-soluble vitamin a preparations for application to the skin |
| 05/09/1997 | WO1997016729A1 Combinatorial dihydrobenzopyran library |
| 05/09/1997 | WO1997016549A2 Molecular cloning and characterization of molecules related to relaxin and the insulin family of ligands |
| 05/09/1997 | WO1997016548A1 NEUROGENIC DIFFERENTIATION (NeuroD) GENES AND PROTEINS |
| 05/09/1997 | WO1997016542A1 Diagnostics and treatments of periodontal disease |
| 05/09/1997 | WO1997016535A2 METHODS FOR USE OF Mpl LIGANDS WITH PRIMITIVE HUMAN STEM CELLS |
| 05/09/1997 | WO1997016532A1 Immunity against actinobacillus pleuropneumoniae's rtx toxins apx |
| 05/09/1997 | WO1997016531A1 Immunity against pasteurella haemolytica leukotoxin |
| 05/09/1997 | WO1997016459A1 Use of protein gax for treating cancer |
| 05/09/1997 | WO1997016457A2 Anti-tumoral protein |
| 05/09/1997 | WO1997016456A1 Novel nucleoside derivatives and process for preparing the same |
| 05/09/1997 | WO1997016455A1 Sugar-substituted 2-azetidinones useful as hypocholesterolemic a gents |
| 05/09/1997 | WO1997016452A1 Purine derivatives and processes for their preparation |
| 05/09/1997 | WO1997016451A1 Fused tropane-derivatives as neurotransmitter reuptake inhibitors |
| 05/09/1997 | WO1997016444A1 Antithrombotic n-amidinopiperidine and benzamidine derivatives |
| 05/09/1997 | WO1997016443A1 Farnesyl transferase inhibiting 2-quinolone derivatives |
| 05/09/1997 | WO1997016442A1 Substituted pyridyl pyrroles, compositions containing such compounds and methods of use |
| 05/09/1997 | WO1997016440A1 1-(1,2-disubstituted piperidinyl)-4-substituted piperazine derivatives |
| 05/09/1997 | WO1997016439A1 Hydroxylamine derivatives useful for enhancing the molecular chaperon production and the preparation thereof |
| 05/09/1997 | WO1997016438A1 Triterpene derivatives with immunosuppressant activity |
| 05/09/1997 | WO1997016437A1 Triterpene derivatives with immunosuppressant activity |
| 05/09/1997 | WO1997016435A1 3,4-diaryl-2-hydroxy-2,5-dihydrofurans as prodrugs to cox-2 inhibitors |
| 05/09/1997 | WO1997016434A1 (-) cis-6(s)-phenyl-5(r)[4-(2-pyrrolidin-1-ylethoxy)phenyl]-5,6,7,8-tetrahydronaphthalen-2-ol d-tartrate |
| 05/09/1997 | WO1997016433A1 Protease inhibitors |
| 05/09/1997 | WO1997016432A1 Processes and intermediates for preparing 1-(2-[2-isoxazol-3-ylbenzofuran-5-yloxy]ethylamino)-3-phenoxy-2(s)-ol |
| 05/09/1997 | WO1997016430A1 Hexahydro-5-imino-1,4-heteroazepine derivatives as inhibitors of nitric oxide synthases |
| 05/09/1997 | WO1997016429A1 Novel piperazinylalkylthiopyrimidine derivatives, pharmaceutical compositions containing the same and a process for the preparation of the novel compounds |
| 05/09/1997 | WO1997016423A1 24-homo-26,27-hexafluoro-cholecalciferols |
| 05/09/1997 | WO1997016418A1 Novel sulfamate compound containing n-substituted carbamoyl group and method for preparing the same |
| 05/09/1997 | WO1997016405A1 New compounds and their compositions having anti-inflammatory and anti-thrombotic activities |
| 05/09/1997 | WO1997016221A2 Genetic induction of receptors for targeted radiotherapy |
| 05/09/1997 | WO1997016209A1 Expression of cyclin g1 in tumors |
| 05/09/1997 | WO1997016204A1 Continuous low-dose cytokine infusion therapy |
| 05/09/1997 | WO1997016196A1 Improved process and composition for therapeutic cisplatin (cddp) |
| 05/09/1997 | WO1997016194A1 Naphthylazo inhibition of amyloidosis |
| 05/09/1997 | WO1997016193A1 Pharmaceutical composition for treating osteoporosis |
| 05/09/1997 | WO1997016191A1 Inhibition of amyloidosis by 9-acridinones |
| 05/09/1997 | WO1997016190A1 Rotamase enzyme activity inhibitors |
| 05/09/1997 | WO1997016189A1 Combination therapy for the treatment of diabetes and obesity |
| 05/09/1997 | WO1997016185A2 A pharmaceutical composition for the treatment of autoimmune diseases |
| 05/09/1997 | WO1997016184A1 Method and pharmaceutical composition for regulating lipid concentration |
| 05/09/1997 | WO1997016183A1 Thiamorphinans with neuroprotective activity |
| 05/09/1997 | WO1997016182A1 Triterpene derivatives with immunosuppressant activity |
| 05/09/1997 | WO1997016181A1 Method for the intranasal administration of l-dopa prodrugs |
| 05/09/1997 | WO1997016180A1 Methods and compositions using butyrate esters of threitol |
| 05/09/1997 | WO1997016179A1 Compositions containing hydroperoxyeicosatetraenoic acid derivatives and methods of use in treating dry eye disorders |
| 05/09/1997 | WO1997016178A1 Stabilised pharmaceutical preparations containing thyroid hormone |
| 05/09/1997 | WO1997016177A1 Method of inhibiting cathepsin k |
| 05/09/1997 | WO1997016175A1 Pure 3r-3'r stereoisomer of zeaxanthin for treating macular degeneration in humans |
| 05/09/1997 | WO1997016174A1 Process for aqueous granulation of clarithromycin |
| 05/09/1997 | WO1997016173A1 New technology for wet granulation |